Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Antengene Corporation Limited ( (HK:6996) ) has shared an update.
Antengene Corporation Limited has announced its intention to conduct an on-market share repurchase, utilizing a mandate approved by shareholders to buy back up to 10% of its issued shares. This move, subject to market conditions, is aimed at demonstrating confidence in the company’s business outlook and enhancing shareholder value, with the repurchase financed by internal resources.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company focused on developing and commercializing innovative oncology medicines. The company operates primarily in the field of cancer treatment, aiming to address unmet medical needs in the Asia-Pacific markets.
YTD Price Performance: 462.50%
Technical Sentiment Signal: Strong Sell
Current Market Cap: €241.8M
For detailed information about 6996 stock, go to TipRanks’ Stock Analysis page.